Detalles de la búsqueda
1.
Five-year follow-up of KEYNOTE-087: pembrolizumab monotherapy for relapsed/refractory classical Hodgkin lymphoma.
Blood
; 142(10): 878-886, 2023 09 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37319435
2.
Incidence and risk factors for central nervous system relapse in patients with primary mediastinal large B-cell lymphoma in the rituximab era.
Hematol Oncol
; 41(1): 97-107, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36314897
3.
A Case Report of Chronic Myelogenous Leukemia Presenting as Blastic Crisis with a T-Cell Acute Lymphoblastic Leukemia Phenotype: Awareness of a Rare Entity.
Acta Haematol
; 146(6): 530-537, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37557081
4.
The Role of mTOR in B Cell Lymphoid Malignancies: Biologic and Therapeutic Aspects.
Int J Mol Sci
; 24(18)2023 Sep 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-37762410
5.
Incorporating Monoclonal Antibodies into the First-Line Treatment of Classical Hodgkin Lymphoma.
Int J Mol Sci
; 24(17)2023 Aug 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-37685994
6.
Serum Procalcitonin Levels in Newly Diagnosed Hodgkin Lymphoma: Correlation with Other Inflammatory Biomarkers.
Medicina (Kaunas)
; 58(10)2022 Sep 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-36295492
7.
Expression of the novel tumour suppressor sterile alpha motif and HD domain-containing protein 1 is an independent adverse prognostic factor in classical Hodgkin lymphoma.
Br J Haematol
; 193(3): 488-496, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33528031
8.
Identification of Very Low-Risk Subgroups of Patients with Primary Mediastinal Large B-Cell Lymphoma Treated with R-CHOP.
Oncologist
; 26(7): 597-609, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33870594
9.
10.
Pembrolizumab in relapsed or refractory Hodgkin lymphoma: 2-year follow-up of KEYNOTE-087.
Blood
; 134(14): 1144-1153, 2019 10 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31409671
11.
Real-life experience with the combination of polatuzumab vedotin, rituximab, and bendamustine in aggressive B-cell lymphomas.
Hematol Oncol
; 39(3): 336-348, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-33583077
12.
Positron emission tomography after response to rituximab-CHOP in primary mediastinal large B-cell lymphoma: impact on outcomes and radiotherapy strategies.
Ann Hematol
; 100(9): 2279-2292, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-33523289
13.
Very Early Onset of Therapy-Related Acute Myeloid Leukemia with 11q23 Rearrangement Presenting with Unusual PET Findings after R-DA-EPOCH for Primary Mediastinal Large B-Cell Lymphoma.
Medicina (Kaunas)
; 58(1)2021 Dec 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-35056356
14.
TACI Mutations in Primary Antibody Deficiencies: A Nationwide Study in Greece.
Medicina (Kaunas)
; 57(8)2021 Aug 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-34441032
15.
Improving outcomes after autologous transplantation in relapsed/refractory Hodgkin lymphoma: a European expert perspective.
BMC Cancer
; 20(1): 1088, 2020 Nov 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33172440
16.
Estimated glomerular filtration rate independently predicts outcome of azacitidine therapy in higher-risk Myelodysplastic syndromes. Results from 536 patients of the Hellenic National Registry of Myelodysplastic and Hypoplastic syndromes.
Hematol Oncol
; 38(4): 541-553, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32495951
17.
A Unique Case of Primary Extranodal Marginal Zone Lymphoma of the Anal Canal.
Acta Haematol
; 142(2): 87-91, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31207598
18.
Rapidly deteriorating B-CLL at presentation: clonally related Burkitt leukemia as an atypical Richter transformation?
Blood
; 137(16): 2272, 2021 04 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-33885712
19.
Treatment intensification might not improve survival in high-grade B-cell lymphoma with a concurrent MYC and BCL2 and/or BCL6 rearrangement: A retrospective, multicenter, pooled analysis.
Hematol Oncol
; 41(4): 776-780, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36945194
20.
The outcome of patients with high-risk MDS achieving stable disease after treatment with 5-azacytidine: A retrospective analysis of the Hellenic (Greek) MDS Study Group.
Hematol Oncol
; 36(4): 693-700, 2018 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-30129144